Showing results (31-40 of 49) with videos related to
Sort By:
Pageof 5
Gynecologic Oncology|September 17, 2011
Accuracy of frozen section diagnosis of ovarian borderline tumorK K Shih, K Garg, R A Soslow, et al.The Journal of Pathology|January 24, 2006
High frequency of beta-catenin mutations in borderline endometrioid tumours of the ovaryE Oliva, D Sarrió, E F Brachtel, et al.Cancer|January 3, 2001
COX-2 is expressed in human pulmonary, colonic, and mammary tumorsR A Soslow, A J Dannenberg, D Rush, et al.Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|January 10, 2002
Cyclooxygenase-2 expression in the developing human kidneyK N Khan, K M Stanfield, A Dannenberg, et al.Oncogene|January 11, 2007
Tumor promoting properties of the ETS protein MEF in ovarian cancerJ J Yao, Y Liu, H D Lacorazza, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
Inducible microsomal prostaglandin E synthase is overexpressed in colorectal adenomas and cancerK Yoshimatsu, D Golijanin, P B Paty, et al.Urology|October 13, 2001
Hand-assisted demucosalized gastrocystoplasty comparing different tissue closure methodsG Pareek, M Specht, D D Lin, et al.Gynecologic Oncology|July 12, 2011
Clinicopathologic significance of DNA mismatch repair protein defects and endometrial cancer in women 40years of age and youngerK K Shih, K Garg, D A Levine, et al.Prostaglandins, Leukotrienes, and Essential Fatty Acids|June 8, 2002
Characterization of cyclooxygenase-2 (COX-2) during tumorigenesis in human epithelial cancers: evidence for potential clinical utility of COX-2 inhibitors in epithelial cancersA T Koki, N K Khan, B M Woerner, et al.Kidney International|December 15, 2000
Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstructionA Miyajima, J Chen, C Lawrence, et al.Pageof 5